Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer

• Váldodahkkit: Maojin You (Dahkki), Ruijia Chen (Dahkki), Qingfeng Wu (Dahkki), Wei Zhu (Dahkki), Ying He (Dahkki), Yufan Huang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: The findings of the CAPSTONE-1 trial showed that adebrelimab in combination with chemotherapy (etoposide-carboplatin) (ADCHM) is clinically beneficial as a first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC), compared with placebo plus chemotherapy (PL...